Further supporting the similarities between the two cancer types is the fact that one of the most common mutations in breast cancer is detected in the PI3KCA gene, which is considered prognostic for targeted anti-PI3K and anti-HER-2 therapy [38]. The gene discussed is ERBB2; the disease is breast carcinoma.